Showing results (1341-1350 of 9,979) with videos related to
Sort By:
Pageof 998
Leukemia & Lymphoma|January 21, 2025
Are we maintaining minimal residual disease in myeloma?Mohammed A Aljama, Hasib M Sidiqi, Morie A GertzLeukemia & Lymphoma|January 22, 2025
Unmet needs and lived experience of patients receiving CAR T-cell therapyPatrick J O'Shea, Patrick Connor Johnson, Areej El-Jawahri, et al.Leukemia & Lymphoma|January 29, 2025
Indolent lymphoma: addressing the needs of survivorsPasquale L Fedele, Stephen OpatLeukemia & Lymphoma|January 17, 2025
Bruton's tyrosine kinase inhibitor zanubrutinib-based regimens in relapsed/refractory primary diffuse large B-cell lymphoma of the central nervous systemYali Wang, Jiefei Han, Shuo Yin, et al.Leukemia & Lymphoma|January 11, 2025
Effects of SCT genetic polymorphisms on methotrexate concentrations and toxicities in Chinese children with acute lymphoblastic leukemiaMiao Li, Dan-Qi Zhao, Xiao-Yan Kong, et al.Leukemia & Lymphoma|January 10, 2025
Frontline immunotherapeutic combination strategies in adult B-cell acute lymphoblastic leukemia: reducing chemotherapy intensity and toxicity and harnessing efficacyJayastu Senapati, Hagop Kantarjian, Diane Habib, et al.Leukemia & Lymphoma|January 10, 2025
gneSeqCOO: a novel method for classifying diffuse large B-cell lymphoma cell of origin based on bulk tumor RNA sequencing profilesWill Harris, Yi Cao, Franck Morschhauser, et al.Leukemia & Lymphoma|January 5, 2025
Advances in the treatment of high burden Follicular lymphoma: a Comprehensive reviewEfrat Luttwak, Anita Kumar, Gilles SallesLeukemia & Lymphoma|December 28, 2024
Outcome of extra-nodal follicular lymphoma affected by choice of induction chemoimmunotherapy and maintenance rituximab - real-world retrospective studyLawrence Cheng Kiat Ng, Shin Yeu Ong, Xinxin Huang, et al.Leukemia & Lymphoma|December 27, 2024
Significance of cycle 1 bone marrow biopsy in predicting outcomes and toxicities of venetoclax-based therapy for myeloid malignanciesJeffrey Baron, Daniel Appiah, Mark G Faber, et al.Pageof 998